TB 402
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
- Thrombosis and haemostasis
- 2013
TB-402 is a long-acting monoclonal antibody that partially inhibits factor VIII. A single administration of TB-402 was effective… (More)
Is this relevant?
2013
2013
- Thrombosis and haemostasis
- 2013
Certain patient groups are at high risk of developing venous thromboembolism (VTE), and those undergoing major orthopaedic… (More)
Is this relevant?
2012
2012
- Journal of thrombosis and haemostasis : JTH
- 2012
BACKGROUND
TB-402 is a partially inhibiting antibody of factor VIII that is under development as a long-acting anticoagulant… (More)
Is this relevant?
2012
2012
- Thrombosis research
- 2012
INTRODUCTION
Partial inhibition of Factor VIII (FVIII) may provide antithrombotic efficacy whilst avoiding excessive… (More)
Is this relevant?
2011
2011
- Journal of thrombosis and haemostasis : JTH
- 2011
BACKGROUND
TB-402 is a novel anticoagulant monoclonal antibody with a prolonged antithrombotic effect resulting from its partial… (More)
Is this relevant?
Review
2011
Review
2011
- Therapeutic advances in cardiovascular disease
- 2011
The therapeutic armamentarium of parenteral anticoagulants available to clinicians is mainly composed by unfractionated heparin… (More)
Is this relevant?
2010
2010
- Clinical therapeutics
- 2010
BACKGROUND
TB-402, a human monoclonal antibody that partially inhibits Factor VIII activity (FVIII:C), is being developed as a… (More)
Is this relevant?